The invention relates to veterinary science and
biotechnology, specifically to the preparation of an anti-
rabies vaccine for the
oral immunization of wild carnivores against
rabies. The anti-
rabies vaccine comprises a
vaccine strain obtained from a fixed
rabies virus, reproduced in a continuous BSR Syrian
hamster kidney cell line, and nutritional and
excipient components. The primary agent used is viral
biomass containing the avirulent
Rabies virus strain
Rabies virus fix / NIIPBB / 2024. Fishmeal and
microcrystalline cellulose, which also contain the marker
tetracycline, are used as food and molding components. The method for producing an oral vaccine against rabies in wild carnivores includes the
reproduction of the
avirulent strain Rabies virus fix / NIIPBB / 2024 in a continuous BSR
cell line by a suspension method using microcarriers or a pseudosuspension method on macrocarriers, carrying out multiple collections of virus-containing
culture fluid every 48 hours with replacement of the maintenance medium, bottling of virus-containing
culture fluid with an infectious activity of at least 6.00 MLD₅₀ / cm³ in 3 g portions into
polyethylene containers, followed by freezing at a temperature of minus 20°C, preparation of a bait composition from
fish meal,
microcrystalline cellulose and
tetracycline, placing the frozen
polyethylene container inside the molded bait, covering the surface of the mold with paraffin and storing the finished vaccine at a temperature of minus 20°C. The technical result consists in increasing the efficiency due to an increase in the antigenic and immunogenic activity of the vaccine.